Table 1.

Characteristics of participants and non-participants

		Participants		Non-participants
Characteristics		N	%	N	%	P-value
No. of patients		470	64	262	36
Age, mean		470	63	262	66	0.02
Gender	Male	248	53	133	51	0.70
	Female	222	47	129	49
Primary tumour site	AML	34	7	9	4	0.02
	CLL	132	28	92	35
	CML	34	7	8	3
	Hodgkin lymphoma	33	7	11	4
	Non-Hodgkin lymphoma	164	35	102	39
	Multiple myeloma	54	11	32	12
	Other1	19	4	8	3
Time since diagnosis	0–6 months	57	13	23	9	0.45
	6–12 months	35	8	23	9
	1–2 years	64	14	49	20
	2–5 years	124	28	56	22
	5–10 years	111	25	61	24
	>10 years	59	13	38	15
Ongoing treatment	Yes	99	22	59	23	0.71
	No	358	78	199	77
Contact type	Hospitalised	24	5	19	7	0.25
	Out-patients	439	95	242	93
Department	Haematological	405	86	222	84	0.70
	Medical	52	11	34	13
	Other2	13	3	6	2
Region	Copenhagen	206	44	121	46	0.19
	Ringkoebing	32	7	26	10
	Funen	232	49	115	44
Formal education3	None	66	17	–		–
	Semi-skilled worker/short education (<1 year)	52	13	–
	Skilled worker	39	10	–
	Short theoretical (1–3 years)	57	15	–
	Long theoretical (>3 years)	133	34	–
	Academic	46	12	–
Civil status3	Married/cohabiting	291	63	–		–
	Divorced/separated	54	12	–
	Unmarried	46	10	–
	Widow/widower	68	15	–
Children3	Yes	386	84	–		–
	No	76	16	–

CLL, chronic lymphocytic leukaemia; CML, chronic myeloid leukaemia; AML, acute myeloid leukaemia.

¹Patients with ALL, myelofibrosis or unclassified leukaemia.

²Patients from departments of surgery and oncology.

³These variables were assessed in participants only.